Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

doi:10.1093/eurjhf/hfs033

Review

. 2012 Apr;14(4):341-3.

doi: 10.1093/eurjhf/hfs033.

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

John J V McMurray¹, William T Abraham, Kenneth Dickstein, Lars Køber, Barry M Massie, Henry Krum

Affiliations

PMID: 22431404
PMCID: PMC3307357
DOI: 10.1093/eurjhf/hfs033

Review

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

John J V McMurray et al. Eur J Heart Fail. 2012 Apr.

. 2012 Apr;14(4):341-3.

doi: 10.1093/eurjhf/hfs033.

Authors

John J V McMurray¹, William T Abraham, Kenneth Dickstein, Lars Køber, Barry M Massie, Henry Krum

Affiliation

¹ BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, UK. john.mcmurray@glasgow.ac.uk

PMID: 22431404
PMCID: PMC3307357
DOI: 10.1093/eurjhf/hfs033

No abstract available

PubMed Disclaimer

Cited by

Effect of vitamin-D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4-5: a retrospective single center study.
Jørgensen HS, Winther S, Povlsen JV, Ivarsen P. Jørgensen HS, et al. BMC Nephrol. 2012 Sep 7;13:102. doi: 10.1186/1471-2369-13-102. BMC Nephrol. 2012. PMID: 22958603 Free PMC article.
Effects of antihypertensive drugs on arterial stiffness.
Dudenbostel T, Glasser SP. Dudenbostel T, et al. Cardiol Rev. 2012 Sep-Oct;20(5):259-63. doi: 10.1097/CRD.0b013e31825d0a44. Cardiol Rev. 2012. PMID: 22573107 Free PMC article. Review.
Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control.
Tocci G, Borghi C, Volpe M. Tocci G, et al. High Blood Press Cardiovasc Prev. 2014 Jun;21(2):107-17. doi: 10.1007/s40292-013-0028-x. Epub 2013 Oct 23. High Blood Press Cardiovasc Prev. 2014. PMID: 24151125
Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension.
Morisawa N, Sugano N, Yamakawa T, Kuriyama S, Yokoo T. Morisawa N, et al. CEN Case Rep. 2017 May;6(1):66-73. doi: 10.1007/s13730-016-0246-x. Epub 2017 Jan 16. CEN Case Rep. 2017. PMID: 28509129 Free PMC article.
Renin Inhibition with Aliskiren: A Decade of Clinical Experience.
Pantzaris ND, Karanikolas E, Tsiotsios K, Velissaris D. Pantzaris ND, et al. J Clin Med. 2017 Jun 9;6(6):61. doi: 10.3390/jcm6060061. J Clin Med. 2017. PMID: 28598381 Free PMC article. Review.

See all "Cited by" articles

References

1. McMurray JJ. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin–angiotensin–aldosterone system the cornerstone of therapy for systolic heart failure. Eur J Heart Fail. 2011;13:929–936. - PubMed
1. Gheorghiade M, Albaghdadi M, Zannad F, Fonarow GC, Böhm M, Gimpelewicz C, Botha J, Moores S, Lewis EF, Rattunde H, Maggioni A ASTRONAUT investigators and study coordinators. Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) Eur J Heart Fail. 2011;13:100–106. - PubMed
1. Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J ATMOSPHERE Investigators. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011;13:107–114. - PubMed
1. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant. 2009;24:1663–1671. - PubMed
1. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Nicolaides M, Richards A, Xiang Z, Armbrecht J, Pfeffer MA. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) J Renin Angiotensin Aldosterone Syst. 2012 in press. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] McMurray JJ. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin–angiotensin–aldosterone system the cornerstone of therapy for systolic heart failure. Eur J Heart Fail. 2011;13:929–936. - PubMed

[2] McMurray JJ. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin–angiotensin–aldosterone system the cornerstone of therapy for systolic heart failure. Eur J Heart Fail. 2011;13:929–936. - PubMed

[3] Gheorghiade M, Albaghdadi M, Zannad F, Fonarow GC, Böhm M, Gimpelewicz C, Botha J, Moores S, Lewis EF, Rattunde H, Maggioni A ASTRONAUT investigators and study coordinators. Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) Eur J Heart Fail. 2011;13:100–106. - PubMed

[4] Gheorghiade M, Albaghdadi M, Zannad F, Fonarow GC, Böhm M, Gimpelewicz C, Botha J, Moores S, Lewis EF, Rattunde H, Maggioni A ASTRONAUT investigators and study coordinators. Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) Eur J Heart Fail. 2011;13:100–106. - PubMed

[5] Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J ATMOSPHERE Investigators. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011;13:107–114. - PubMed

[6] Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J ATMOSPHERE Investigators. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011;13:107–114. - PubMed

[7] Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant. 2009;24:1663–1671. - PubMed

[8] Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant. 2009;24:1663–1671. - PubMed

[9] Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Nicolaides M, Richards A, Xiang Z, Armbrecht J, Pfeffer MA. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) J Renin Angiotensin Aldosterone Syst. 2012 in press. - PubMed

[10] Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Nicolaides M, Richards A, Xiang Z, Armbrecht J, Pfeffer MA. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) J Renin Angiotensin Aldosterone Syst. 2012 in press. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

Affiliation

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources